285 related articles for article (PubMed ID: 29979914)
1. Compromised phagosome maturation underlies RPE pathology in cell culture and whole animal models of Smith-Lemli-Opitz Syndrome.
Ramachandra Rao S; Pfeffer BA; Más Gómez N; Skelton LA; Keiko U; Sparrow JR; Rowsam AM; Mitchell CH; Fliesler SJ
Autophagy; 2018; 14(10):1796-1817. PubMed ID: 29979914
[TBL] [Abstract][Full Text] [Related]
2. Oxysterols and Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome: Implications for an Improved Therapeutic Intervention.
Fliesler SJ; Xu L
Molecules; 2018 Oct; 23(10):. PubMed ID: 30360379
[TBL] [Abstract][Full Text] [Related]
3. Retinal degeneration in a rodent model of Smith-Lemli-Opitz syndrome: electrophysiologic, biochemical, and morphologic features.
Fliesler SJ; Peachey NS; Richards MJ; Nagel BA; Vaughan DK
Arch Ophthalmol; 2004 Aug; 122(8):1190-200. PubMed ID: 15302661
[TBL] [Abstract][Full Text] [Related]
4. Light-induced exacerbation of retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome.
Vaughan DK; Peachey NS; Richards MJ; Buchan B; Fliesler SJ
Exp Eye Res; 2006 Mar; 82(3):496-504. PubMed ID: 16360150
[TBL] [Abstract][Full Text] [Related]
5. Alteration of retinal rod outer segment membrane fluidity in a rat model of Smith-Lemli-Opitz syndrome.
Boesze-Battaglia K; Damek-Poprawa M; Mitchell DC; Greeley L; Brush RS; Anderson RE; Richards MJ; Fliesler SJ
J Lipid Res; 2008 Jul; 49(7):1488-99. PubMed ID: 18344409
[TBL] [Abstract][Full Text] [Related]
6. 7-Dehydrocholesterol-derived oxysterols and retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome.
Xu L; Sheflin LG; Porter NA; Fliesler SJ
Biochim Biophys Acta; 2012 Jun; 1821(6):877-83. PubMed ID: 22425966
[TBL] [Abstract][Full Text] [Related]
7. Lipid-derived and other oxidative modifications of retinal proteins in a rat model of Smith-Lemli-Opitz syndrome.
Kapphahn RJ; Richards MJ; Ferrington DA; Fliesler SJ
Exp Eye Res; 2019 Jan; 178():247-254. PubMed ID: 30114413
[TBL] [Abstract][Full Text] [Related]
8. Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome.
Keller RK; Arnold TP; Fliesler SJ
J Lipid Res; 2004 Feb; 45(2):347-55. PubMed ID: 14594996
[TBL] [Abstract][Full Text] [Related]
9. Abnormal cholesterol biosynthesis as in Smith-Lemli-Opitz syndrome disrupts normal skeletal development in the rat.
Kolf-Clauw M; Chevy F; Ponsart C
J Lab Clin Med; 1998 Mar; 131(3):222-7. PubMed ID: 9523845
[TBL] [Abstract][Full Text] [Related]
10. Signaling by the human serotonin(1A) receptor is impaired in cellular model of Smith-Lemli-Opitz Syndrome.
Paila YD; Murty MR; Vairamani M; Chattopadhyay A
Biochim Biophys Acta; 2008 Jun; 1778(6):1508-16. PubMed ID: 18381059
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol deficit but not accumulation of aberrant sterols is the major cause of the teratogenic activity in the Smith-Lemli-Opitz syndrome animal model.
Gaoua W; Wolf C; Chevy F; Ilien F; Roux C
J Lipid Res; 2000 Apr; 41(4):637-46. PubMed ID: 10744785
[TBL] [Abstract][Full Text] [Related]
12. Modeling Smith-Lemli-Opitz syndrome with induced pluripotent stem cells reveals a causal role for Wnt/β-catenin defects in neuronal cholesterol synthesis phenotypes.
Francis KR; Ton AN; Xin Y; O'Halloran PE; Wassif CA; Malik N; Williams IM; Cluzeau CV; Trivedi NS; Pavan WJ; Cho W; Westphal H; Porter FD
Nat Med; 2016 Apr; 22(4):388-96. PubMed ID: 26998835
[TBL] [Abstract][Full Text] [Related]
13. An efficient synthesis of 4α- and 4β-hydroxy- 7-dehydrocholesterol, biomarkers for patients with and animal models of the Smith-Lemli-Opitz syndrome.
Kawamoto H; Ohmori Y; Maekawa M; Shimada M; Mano N; Iida T
Chem Phys Lipids; 2013; 175-176():73-8. PubMed ID: 23920082
[TBL] [Abstract][Full Text] [Related]
14. Retinal degeneration in a rat model of Smith-Lemli-Opitz Syndrome: thinking beyond cholesterol deficiency.
Fliesler SJ
Adv Exp Med Biol; 2010; 664():481-9. PubMed ID: 20238050
[TBL] [Abstract][Full Text] [Related]
15. Novel oxysterols observed in tissues and fluids of AY9944-treated rats: a model for Smith-Lemli-Opitz syndrome.
Xu L; Liu W; Sheflin LG; Fliesler SJ; Porter NA
J Lipid Res; 2011 Oct; 52(10):1810-20. PubMed ID: 21817059
[TBL] [Abstract][Full Text] [Related]
16. Lipidomic analysis of the retina in a rat model of Smith-Lemli-Opitz syndrome: alterations in docosahexaenoic acid content of phospholipid molecular species.
Ford DA; Monda JK; Brush RS; Anderson RE; Richards MJ; Fliesler SJ
J Neurochem; 2008 May; 105(3):1032-47. PubMed ID: 18182048
[TBL] [Abstract][Full Text] [Related]
17. Aripiprazole and trazodone cause elevations of 7-dehydrocholesterol in the absence of Smith-Lemli-Opitz Syndrome.
Hall P; Michels V; Gavrilov D; Matern D; Oglesbee D; Raymond K; Rinaldo P; Tortorelli S
Mol Genet Metab; 2013; 110(1-2):176-8. PubMed ID: 23628460
[TBL] [Abstract][Full Text] [Related]
18. Differential cytotoxic effects of 7-dehydrocholesterol-derived oxysterols on cultured retina-derived cells: Dependence on sterol structure, cell type, and density.
Pfeffer BA; Xu L; Porter NA; Rao SR; Fliesler SJ
Exp Eye Res; 2016 Apr; 145():297-316. PubMed ID: 26854824
[TBL] [Abstract][Full Text] [Related]
19. Absence of ventral cell populations in the developing brain in a rat model of the Smith-Lemli-Opitz syndrome.
Gofflot F; Kolf-Clauw M; Clotman F; Roux C; Picard JJ
Am J Med Genet; 1999 Nov; 87(3):207-16. PubMed ID: 10564872
[TBL] [Abstract][Full Text] [Related]
20. Hepatic isoprenoid metabolism in a rat model of Smith-Lemli-Opitz Syndrome.
Keller RK; Mitchell DA; Goulah CC; Fliesler SJ
Lipids; 2013 Mar; 48(3):219-29. PubMed ID: 23361583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
